Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$53.6M |
| 2 |
Strategy Inc
MSTR
|
+$39M |
| 3 |
International Paper
IP
|
+$25.9M |
| 4 |
DoorDash
DASH
|
+$22.6M |
| 5 |
United Airlines
UAL
|
+$21.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$712M |
| 2 |
Apple
AAPL
|
+$125M |
| 3 |
Interactive Brokers
IBKR
|
+$38.1M |
| 4 |
NVIDIA
NVDA
|
+$28.5M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$27.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.44% |
| 2 | Healthcare | 11.83% |
| 3 | Consumer Discretionary | 11.73% |
| 4 | Communication Services | 9.55% |
| 5 | Industrials | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRP.U
1551
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $2.96M | ﹤0.01% |
63,500
| – | – |
|
1552
Integra LifeSciences
IART
$1.42B
| $2.96M | ﹤0.01% |
134,594
+4,900
| +4% | +$115K |
|
1553
Lakeland Financial Corp
LKFN
$1.55B
| $2.94M | ﹤0.01% |
49,450
-700
| -1% | -$45.9K |
|
1554
NETSCOUT
NTCT
$2.88B
| $2.92M | ﹤0.01% |
139,028
-1,100
| -0.8% | -$24.7K |
|
1555
Reynolds Consumer Products
REYN
$5.54B
| $2.92M | ﹤0.01% |
122,200
-1,800
| -1% | -$45.4K |
|
1556
Agios Pharmaceuticals
AGIO
$1.99B
| $2.91M | ﹤0.01% |
99,460
-1,300
| -1% | -$43.1K |
|
|
MAG
1557
DELISTED
MAG Silver
MAG
| $2.91M | ﹤0.01% |
191,300
-2,600
| -1% | -$40.3K |
|
|
APLS
1558
DELISTED
Apellis Pharmaceuticals
APLS
| $2.9M | ﹤0.01% |
132,600
-11,100
| -8% | -$307K |
|
1559
Nicolet Bankshares
NIC
$3.73B
| $2.9M | ﹤0.01% |
26,600
| – | – |
|
1560
Customers Bancorp
CUBI
$2.82B
| $2.9M | ﹤0.01% |
57,700
-1,500
| -3% | -$78.7K |
|
1561
AvePoint
AVPT
$2.86B
| $2.89M | ﹤0.01% |
199,800
-2,200
| -1% | -$37K |
|
1562
Pitney Bowes
PBI
$2.25B
| $2.88M | ﹤0.01% |
317,800
| – | – |
|
1563
Hilltop Holdings
HTH
$2.26B
| $2.87M | ﹤0.01% |
94,400
-1,200
| -1% | -$36.5K |
|
|
AVDX
1564
DELISTED
AvidXchange
AVDX
| $2.87M | ﹤0.01% |
338,800
+11,800
| +4% | +$109K |
|
1565
IES Holdings
IESC
$15.1B
| $2.87M | ﹤0.01% |
17,400
-200
| -1% | -$41.7K |
|
1566
BioCryst Pharmaceuticals
BCRX
$2.44B
| $2.86M | ﹤0.01% |
381,268
-5,300
| -1% | -$42.8K |
|
1567
ODDITY Tech
ODD
$609M
| $2.86M | ﹤0.01% |
66,100
+3,900
| +6% | +$173K |
|
1568
Carter's
CRI
$1.41B
| $2.85M | ﹤0.01% |
69,800
-1,400
| -2% | -$67.3K |
|
1569
Tarsus Pharmaceuticals
TARS
$3.04B
| $2.85M | ﹤0.01% |
55,533
+3,200
| +6% | +$158K |
|
|
SILA
1570
DELISTED
Sila Realty Trust
SILA
| $2.85M | ﹤0.01% |
+106,581
| New | +$2.66M |
|
1571
Levi Strauss
LEVI
$8.69B
| $2.85M | ﹤0.01% |
182,600
-2,200
| -1% | -$38.3K |
|
1572
NuScale Power
SMR
$3.8B
| $2.83M | ﹤0.01% |
200,100
+32,400
| +19% | +$655K |
|
1573
Travere Therapeutics
TVTX
$5.85B
| $2.83M | ﹤0.01% |
158,100
+6,200
| +4% | +$126K |
|
1574
GeneDx Holdings
WGS
$2.33B
| $2.83M | ﹤0.01% |
31,900
+8,100
| +34% | +$703K |
|
1575
National Bank Holdings
NBHC
$1.94B
| $2.82M | ﹤0.01% |
73,700
-800
| -1% | -$33.3K |
|
Similar funds
Swiss National Bank's Q1 2025 Portfolio in Review
As of Q1 2025, Swiss National Bank held 2,478 positions worth $142B, down 5.8% from $150B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 4.8%. Swiss National Bank opened 38 new positions and exited 81, leaving the 2,478-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q1 2025 buy was United Airlines: 231,900 shares worth $16M.
- Swiss National Bank added most to Visa in Q1 2025, an estimated $53.6M increase.
- Swiss National Bank's biggest Q1 2025 reduction was Apple, cutting an estimated $125M.
- Swiss National Bank fully exited Chevron in Q1 2025, selling an estimated $712M.
- Swiss National Bank's ten largest holdings make up 31% of its $142B portfolio in Q1 2025.
- Swiss National Bank opened 38 new positions and closed 81 in Q1 2025.
- Swiss National Bank's portfolio value fell 5.8% quarter-over-quarter to $142B.
Based on Swiss National Bank's 13F filing for Q1 2025, filed 12 May 2025.